Ceramide, a product of agonist-stimulated sphingomyelinase activation, is known to be generated during the phagocytosis of antibody-coated erythrocytes by polymorphonuclear leukocytes. Agonist-stimulated formation of ceramide-1-phosphate is now shown to occur in 32 PO 4 -labeled neutrophils. Ceramide-1-phosphate is formed by a calcium-dependent ceramide kinase, found predominately in the neutrophil plasma membrane. The neutrophil kinase is specific for ceramide because, in contrast to the bacterial diglyceride kinase, ceramide is not phosphorylated under conditions specific for diglyceride phosphorylation. Conversely, 1,2-diacylglycerol does not serve as substrate for the neutrophil ceramide kinase. Ceramide kinase activation occurs in a time-dependent fashion, reaching peak activity 10 min after formyl peptide stimulation and challenge with antibody-coated erythrocytes. The lipid kinase activity is optimal at pH 6.8. Because the formation of the phagolysosome is a critical event in phagocytosis, the effect of ceramide-1-phosphate in promoting the fusion of liposomes was determined. Both the addition of increasing concentrations of sphingomyelinase D and ceramide-1-phosphate promoted liposomal fusion. In summary, ceramide-1-phosphate is formed during phagocytosis through activation of ceramide kinase. Ceramide-1-phosphate may promote phagolysosome formation.
Polymorphonuclear leukocytes (PMNs) 1 participate in host defense by releasing antimicrobial proteins from intracellular granules into phagosomes. A number of highly specialized functions, including chemotaxis, adhesion, superoxide production, and secretion of hydrolytic enzymes, permit PMNs to accomplish this complex task (1, 2) . The signaling pathways involved in phagocytosis are determined by the activation state of the PMN, as well as by the type of agonist used for activation. Membrane fusion plays an important role in the degranulation process by creating a pathway by which granule contents have access to phagosomes or to the extracellular milieu. Although the conditions required for PMN activation have been extensively studied, much remains to be learned about the cofactors and mechanisms that promote fusion between granules and the plasma membrane. Recently it has been shown that Ca 2ϩ alone does not promote fusion between neutrophil granules and plasma membrane fractions using a cell-free fusion assay (3) . Therefore, other components must be required to bring about phagolysosomal formation. These components likely include annexin, VAMP-2, and lipids (4, 5) .
Presently, the lipid signaling pathways leading to these complex events have not been clearly defined. The agonist-stimulated hydrolysis of membrane phospholipids produces potent second messengers. Among these messengers is diacylglycerol, generated indirectly by phosphatidic phosphohydrolase acting on phosphatidic acid generated by phospholipase D. Phospholipase D activation accompanies phagocytosis mediated by Fc receptors in the PMN. Inhibition of either phospholipase D or phosphatidic acid phosphohydrolase prevents the PMN phagocytic response. Diacylglycerol formed by the hydrolysis of phosphatidylinositol-4,5-bisphosphate or indirectly through the phospholipase D pathway is a potent activator of protein kinase C␦, which in turn stimulates the Raf-MEK-MAP (Raf/ mitogen-activated protein kinase kinase kinase/mitogen-activated protein kinase) pathway (6, 7) . The mitogen-activated protein kinase pathway is also required for phagocytosis to ensue (8) . Sphingosine formed from ceramide by the enzymatic activity of ceramidase inhibits phagocytosis by blocking the action of protein kinase C␦ as well as inhibiting the formation of diacylglycerol by phosphatidic phosphohydrolase.
We recently observed that ceramide is generated at a time when the respiratory burst is terminated, indicating that ceramide may function as a critical component of receptor-mediated signaling in PMNs (9) . In support of this hypothesis, the addition of cell-permeable ceramides blocks oxidant release (4) .
In the last decade it has become evident that sphingolipids, in addition to being structural components of membranes, have multiple biological activities: regulating cell-cell and cell-substrate interactions and differentiation (10, 11) . Direct evidence for a role of ceramides in signal transduction has come from studies using exogenous sphingomyelinase and cell-permeable ceramides to duplicate receptor-mediated activation. Sphingomyelinase and short chain ceramides have been used to implicate ceramides in such diverse processes as apoptosis, Ca 2ϩ influx, superoxide generation, proliferation, and cell cycle regulation (12) (13) (14) (15) (16) .
With the recent cloning of the neutral sphingomyelinase and its overexpression in the U937 cell line, some of the functional effects of the exogenous cell-permeable ceramide have been questioned (17) . On the other hand, there is a general consensus that ceramide blocks the activation of phospholipase D in fibroblasts and PMNs (9, 18, 19) . Ceramides may therefore contribute to the attenuation of the phagocytic response in these cells. A novel pathway has previously been suggested to occur in HL-60 cells and synaptic vesicles at the plasma membrane wherein ceramide produced as a result of sphingomyelinase, but not beta glucosidase, is rapidly phosphorylated by a calcium-dependent ceramide kinase (20 -22) . Because of the effects on PMN function previously observed with ceramide, we determined whether ceramide could be metabolized to ceramide-1-phosphate in PMNs and whether the latter product might be functionally significant.
In the present study we report that PMNs labeled with [ 32 Methods-Cells-Human PMNs were isolated from human peripheral blood as described previously (4) . Briefly, fresh whole blood was obtained by venipuncture from healthy volunteers and immediately added to acid citrate dextrose. The PMNs were purified by dextran sedimentation followed by hypotonic lysis to remove the majority of erythrocytes and then centrifuged through Ficoll-Paque to remove contaminating mononuclear cells. Before activation of PMNs and subcellular fractionation, cells were incubated for 5 min on ice with 5 mM diisopropylfluorophosphate, washed, and resuspended in the desired buffer.
Phagocytosis Assay-Sheep erythrocytes were opsonized with antisheep erythrocyte IgG as described previously (9) . Phagocytosis assays were conducted essentially as outlined by Pommier (23) . PMNs were preactivated with fMLP (100 nM) for 10 min at 37°C, then EIgG (1 ϫ 10 8 /ml) were added to the activated PMNs, and the activation was continued for an additional 30 min at 37°C. Subcellular Fractionation-Subcellular fractionation was performed as described previously by Kjeldsen et al. (24) . Diisopropylfluorophosphate-treated PMNs (control cells, fMLP-preactivated cells, or fMLPpreactivated-phagocytosing cells) were resuspended at 1.5-5 ϫ 10 7 /ml in disruption buffer (100 mM KCl, 3 mM NaCl, 1 mM Na 2 ATP, 3.5 mM MgCl 2 , 10 mM piperazine, N, NЈ-bis-2-ethanolsulfonic acid, pH 7.2) containing 0.5 mM phenylmethylsulfonyl fluoride and 1 g/ml each of pepstatin, leupeptin, and aprotinin and 10 g/ml soybean trypsin inhibitor. Cells were disrupted by nitrogen cavitation, nuclei and unbroken cells were removed by centrifugation, and the postnuclear supernatant was applied to a discontinuous Percoll gradient (1.05/1.09/1.12 g/ml). The gradient was centrifuged at 37,000 ϫ g for 30 min, resulting in four visible bands. These bands consisted of (from the bottom) the ␣-band, containing azurophil granules; the ␤ 1 -band, containing specific granules; the ␤ 2 -band, containing gelatinase granules; and a ␥-band, containing light membranes including secretory vesicles and plasma membranes. The clear cytosol was on top. The gradient was collected as 35 fractions by aspiration from the bottom of the tube. All fractions were assayed for myeloperoxidase (an azurophil granule marker), lactoferrin (a specific granule marker), gelatinase (a gelatinase granule marker), HLA class I (a plasma membrane marker), and latent alkaline phosphatase (a marker for secretory vesicles). All marker proteins were measured by enzyme-linked immunosorbent assay, as described previously (24) , with the exception of alkaline phosphatase enzymatic assay (25) . The membrane pellets were washed once in phophate-buffered saline and stored at 4°C.
Ceramide-1-phosphate Standard-Ceramide-1-phosphate was synthesized by use of sphingomyelinase D from spider venom. Sphingomyelin (10 mg) was dissolved in chloroform and evaporated under nitrogen. A buffer consisting of 0.5 ml of 50 mM HEPES, pH 6.8, 100 mM KCl, 1 mM EGTA, and 3 mM CaCl 2 was added to the dried lipid, and the mixture was probe-sonicated for 1 min. One mg of spider venom sphingomyelinase D was added, and the mixture was incubated for 3 h at 30°C. The lipids were extracted as described previously (26, 27) and developed on high performance TLC in chloroform/acetone/methanol/ acetic acid/water (10:4:3:2:1, v/v). The corresponding spot for ceramide-1-phosphate was identified using the radiolabeled standard, scraped, eluted, and checked again for purity by high performance TLC after mild alkaline hydrolysis.
Lipid Kinase Assays-Kinase activity was measured as described by Bajjalieh et al. (22) . Sonicated cells or membrane fractions were incubated for 10 min at 30°C in a reaction mixture containing 5 M lipid (ceramide or diacylglycerol), 50 mM HEPES, pH 6.8, 100 mM KCl, 1 mM EGTA, 10 M [␥-32 P]ATP (4 Ci/mmol), and 3 mM CaCl 2 . The reaction was stopped with 4 ml of chloroform/methanol (1:1) and 1 ml of 1 M NaCl. The mixture was vortexed and then centrifuged for 5 min at 800 ϫ g. The lower layer was washed twice with 2 ml of 1% HClO 4 . An equal volume of the chloroform phase was removed and dried under nitrogen. Glycerophospholipids were degraded by mild alkaline hydrolysis in 0.2 M NaOH in methanol at room temperature for 2 h. This step was omitted in studies where diacylglycerol was the substrate. Identification of the reaction product was based on comparison of the reaction product ceramide-1-phosphate to standard in several TLC solvent systems and on the demonstration that ceramide-1-phosphate was resistant to mild alkaline hydrolysis. The three systems included chloroform/ acetone/methanol/acetic acid/water (40:15:13:12:8, v/v), chloroform/ methanol/acetic acid/water (65:43:1:3, v/v), and chloroform/acetone/ methanol/acetic acid/water (10:4:3:2:1,v/v), with the latter system run on an oxalate-impregnated plate (28) . The third system was employed for further assays. The products were visualized by autoradiography and quantified by liquid scintillation counting. Enzyme activity was determined from the percent conversion of substrate to product and the specific radioactivity of [␥-32 P]ATP. For determination of pH dependence, three different buffers were used: 50 mM citric acid-sodium citrate buffer, pH 3.0 -6.2; 50 mM HEPES, pH 6.2-6.8; and 50 mM Trismaleate, pH 6.8 -8. 4 .
Diacylglycerol Kinase Assay-The method described by Kanoh et al. (29) was employed. The reaction mixture contained in a final volume of 125 l, 100 mM Tris-HCl, pH 7.4, 20 mM NaF, 1.0 mM deoxycholate, 1.6 mM [␥-32 P]ATP, 10 mM MgCl 2 , and plasma membranes. Immediately before incubations, diacylglycerol was sonicated in the Tris-HCl buffer containing deoxycholate, NaF, and dithiothreitol. The sonication was conducted at 0°C for 5 min at maximum intensity using a microprobe Branson Sonifier. The reaction mixture was incubated for 7 min at 30°C, and the reaction was stopped by the addition of 50 l of concentrated HCl to tubes followed by 1.5 ml of water. The reaction products were then extracted with 1.0 ml of 1-butanol. When the enzyme was assayed with phosphatidylserine, the reaction conditions were the same as those described for the standard incubation except for the omission of deoxycholate. Diacylglycerol was sonicated without detergent immediately before the incubation.
32
P-Labeling of PMNs-PMNs (75 ϫ 10 6 /ml) were incubated with 18.75 l of carrier-free H 3 [ 32 P]O 4 (10 mCi/ml) at room temperature in a buffer consisting of 30 mM HEPES, 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 10 mM glucose, 2 mg/ml bovine serum albumin, pH 7.4. After incubation, the PMNs were diluted and washed twice in phosphatebuffered saline before the measurement of phagocytosis. The reaction was terminated by the centrifugation of the PMNs, removal of the supernatant, and the addition of 2 ml methanol. After transferring the samples to a glass tube, 2 ml of methanol and 8 ml of chloroform were added, and the sample was resonicated for 30 s in a bath sonicator and centrifuged for 30 min at 3000 ϫ g. The supernatant was saved, and the pellets were re-extracted with 6 ml of chloroform/methanol (2/1,v/v) and sonicated for 30 s. The sample was centrifuged for 15 min at 3000 ϫ g, the supernatants were combined with those of the first extraction, and 4.8 ml of 1 M NaCl were added. After centrifugation for 5 min at 2000 ϫ g, the lower layer was transferred to another tube and subjected to mild alkaline hydrolysis. The lipids were dried under nitrogen, dissolved in chloroform/methanol (2:1), and applied to high performance TLC plates,
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which were developed using the system described above. The corresponding spots for ceramide-1-phosphate were identified by comigration with a radiolabeled standard, scraped, and quantitated by liquid scintillation.
Liposome Preparation-Calcium buffers were prepared in buffer A (50 mM HEPES, 100 mM KCl, 1 mM EGTA, pH 7.0) such that dilutions gave a range of final ionized [Ca 2ϩ ] (100 nM to 14 mM) as predicted using the system of Bers (30) and measured using a Ca 2ϩ -sensitive electrode (Orion Research, Inc., Boston, MA). For liposome preparation, phospholipids were mixed, dried under argon, and redissolved in diethyl ether. Complex liposomes were prepared with a molar ratio of phsophatidylcholine/phosphatidylethanolamine/phosphatidylinositol/phosphatidylserine/sphingomyelin of 24:27:16:13:20 with 50 mol % cholesterol. This phospholipid composition was chosen to resemble that of neutrophil plasma membrane (31) , partially replacing phosphatidylcholine with additional sphingomyelin. To prepare NBD Rh liposomes, 1% NBDphosphatidylethanolamine and 1% Rh-phosphatidylethanolamine were added to the initial phospholipid mixture before drying. Phospholipids dissolved in diethyl ether were emulsified with buffer A, and large unilamellar vesicles were prepared by reverse phase evaporation (32, 33) . After evaporation, liposomes were extruded three times through a 0.1-m filter to ensure uniform size.
Fusion Assay-Fusion was measured by liposome dilution as described previously (34) . Briefly, large unilamellar vesicles containing 1% NBD-phosphatidylethanolamine and 1% rhodamine phosphatidylethanolamine were formed such that the distance between NBD and rhodamine was sufficiently close that the rhodamine quenched the NBD fluorescence. Liposomes (300 mg of total phospholipids, 9:1 unlabeled to labeled vesicles) and sphingomyelinase D were combined in a cuvette and incubated with the addition of calcium. The fluorescence was measured continuously on an SLM 8000 spectofluorometer for 90 s. Fusion between an unlabeled liposome or granule and a labeled vesicle resulted in an increase in the distance between NBD and rhodamine and a decrease in fluorescence-quenching. Ca 2ϩ -induced vesicle lysis was controlled for by monitoring the signal in the absence of unlabeled vesicles.
RESULTS

Endogenous Formation of Ceramide-1-phosphate in PMNs-
Previous work has demonstrated the existence of phagocytosisdependent ceramide formation in PMNs (9) . To ascertain whether ceramide-1-phosphate was also formed during phagocytosis, PMNs were labeled with H 3 [ 32 P]O 4 , the lipids were extracted, and the product profile was evaluated in several TLC solvent systems by comparison to known standards. When the labeled cell extract was developed in chloroform/acetone/ methanol/acetic acid/water 10:4:3:2:1, v/v), a labeled product comigrating with ceramide-1-phosphate (R f 0.37) was detected. This product was resistant to alkaline hydrolysis and was clearly separable from phosphatidic acid (R f 0.52) and lysophosphatidic acid (R f 0.27).
Ceramide- 4 and then stimulated with 100 nM fMLP for 10 min, no significant change in ceramide-1-phosphate labeling was observed. However, if the fMLP-primed PMNs were challenged with EIgG for 10 additional min, ceramide-1-phosphate activity increased by 187% compared with time-matched control cells. The addition of EIgG in the absence of fMLP priming resulted in no significant change in ceramide-1-phosphate labeling (Fig. 1) . Thus only fMLP-primed cells challenged with EIgG demonstrated increased ceramide-1-phosphate labeling over basal levels.
The increase in ceramide-1-phosphate labeling paralleled both the observed increase in ceramide levels and the greater increase in phagocytic index seen with PMNs primed with fMLP (104 Ϯ 14, mean ϮS.D., n ϭ 3) compared with unprimed cells (24 Ϯ 14) as previously reported (9) . Thus fMLP appears to be necessary but not sufficient for the formation of ceramide and ceramide-1-phosphate and the induction of phagocytosis in suspended PMNs.
Identification of Ceramide Kinase Activity in Subcellular Fractions of PMNs-A subcellular fractionation of PMNs was performed on a three layer Percoll density gradient to determine whether both ceramide kinase activity and ceramide were present in PMN plasma membranes (Fig. 2, top panel) . This fractionation resolved known mobilizable subsets of granules and secretory vesicles in human PMNs. Secretory vesicles (identified by latent alkaline phosphatase) and plasma membranes (recognized by HLA class I) were present in the lightmembrane region. The profiles of these two markers overlapped with the secretory vesicles being slightly denser and extending lower into the gradient and the plasma membranes being slightly lighter and remaining in the upper part of the gradient. The cytosol was present above the light membrane fractions (fractions 25 to 35).
The subcellular fractions were assayed for the presence of ceramide kinase activity. Although ceramide was present in all fractions, the lipid kinase activity was primarily localized in plasma membrane fractions (1.64 Ϯ 0.8 pmol/min/mg of protein). A lower activity was detected in the cytosolic fractions (0.49 Ϯ 0.09 pmol/min/mg of protein) (Fig. 2, bottom panel) .
These initial data were consistent with the presence of ceramide kinase activity in the PMN plasma membrane. The E. coli diglyceride kinase phosphorylates both diacylglycerol and ceramide. By contrast, ceramide has not been demonstrated to be a substrate for mammalian diglyceride kinase. It was reasonable to determine whether the formation of ceramide-1-phosphate was the result of a Ca 2ϩ -dependent ceramide kinase or whether a Mg 2ϩ -dependent diacylglycerol kinase activity might be responsible for the ceramide kinase activity. If the PMN diglyceride kinase is responsible for the synthesis of ceramide-1-phosphate, then 1,2-diacylglycerol should demonstrate competitive inhibition of ceramide for such a diacylglycerol kinase but not for the ceramide kinase. When ceramide (0.1 mM) was used as substrate, increasing concentrations of 
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1,2-diacylglycerol (0.1 to 3.0 mM) failed to inhibit calcium-dependent ceramide phosphorylation even though there was a concentration-dependent increase in phosphatidic acid (Fig.  3A) . Moreover, ceramide phosphorylation was blocked in the presence of 25 mM MgCl 2 in the reaction mixture (Fig. 3B) . Finally, when 1,2 diacyglycerol (0.1 mM) was present, increasing concentrations of ceramide (0.1 to 3.0 mM) failed to diminish phosphatidic acid formation (Fig. 3C) . These data are consistent with the presence of separate calcium-dependent diglyceride kinase and ceramide kinase activities.
When incubations were performed in the presence of phosphatidylserine, a known activator of most diglyceride kinases (29) , ceramide kinase activity declined with increasing phosphatidylserine concentrations (Fig. 4) . Amphiphilic detergents such as deoxycholate are known activators of diglyceride kinase. Therefore, ceramide kinase activity was assayed in plasma membrane fractions using ceramide or dioleoylglycerol as substrate in the assay system containing deoxycholate. Ceramide-1-phosphate formation was not observed under these assay conditions (data not shown). These data are consistent with the interpretation that the lipid kinase activity in PMNs, responsible for ceramide-1-phosphate formation, is a ceramide kinase distinct from diglyceride kinase.
Characterization of PMN Ceramide Kinase Activity-The effects of calcium and magnesium on the phosphorylation of ceramide were also studied (Fig. 5) . The ceramide kinase activity varied between 6.09 Ϯ 0.9 and 17.69 Ϯ 0.89 pmol/min/2 ϫ 
FIG. 3. Increasing concentrations of diacylglycerols do not inhibit calcium-dependent ceramide phosphorylation (Cer-1-P).
Ceramide kinase was measured as described under "Methods" section. For panels A and B a constant concentration of ceramide (0.1 mM) and varying concentrations of 1,2-dioleoylglycerol (0.1 to 3 mM) were employed. The Ca 2ϩ and Mg 2ϩ concentrations were 3 mM and 25 mM, respectively, for the individual experiments. C, ceramide kinase was measured with a constant concentration of 1,2 dioleoylglycerol (0.1 mM), and the ceramide concentrations were varied. Ca 2ϩ (3 mM) but not Mg 2ϩ was present in the assay buffer. PA, phosphatidic acid; Org., origin.
FIG. 4.
Inhibition of PMN ceramide kinase activity by phosphatidylserine. Kinase activity was determined by production of labeled ceramide-1-phosphate as described under "Methods" with the concentrations of phosphatidylserine varied as indicated. Results are the mean ϮS.D. of three independent experiments. 6 cell equivalents when free Ca 2ϩ was varied between 0 and 5 mM. In contrast, diacylglycerol kinase activity was unaffected by any change in free calcium concentration (data not shown). Mg 2ϩ depressed ceramide kinase activity at all concentrations studied.
The pH dependence of PMN ceramide kinase activity was assessed (Fig. 6) . No measurable activity was observed at pH values less than 5. Maximal calcium-dependent ceramide phosphorylation occurred at pH 6.8 and rapidly fell to a minimal level at pH 8.2. The activity was therefore optimal within a physiological pH range.
Lineweaver-Burke analysis of ceramide kinase activity was obtained with varying concentrations of ATP (0.01 M-10 mM). An apparent V max ϭ 0.820 pmol/min/mg of protein and an apparent K m ϭ 13.08 M for ATP were determined.
Effect of Cellular Stimulation on Ceramide Kinase Activity-It has been previously reported that activation of a Mg 2ϩ -dependent, neutral sphingomyelinase and ceramide formation occurs during phagocytosis (35) . Ceramide kinase activity increased for 10 min after fMLP stimulation and EIgG challenge (Fig. 7) . Activity rapidly fell by 15 min to levels approaching the basal inactivated state.
Effect of Ceramide-1-Phosphate on Complex Liposome Fusion-Changes in granule and/or plasma membrane phospholipid composition may alter their fusogenic potential and, thus, may serve as one mechanism to regulate granule-plasma membrane fusion. The Ca 2ϩ requirements for liposome fusion in control "complex" liposomes with a phospholipid composition that resembled that of human PMN plasma membranes were determined. The threshold for complex liposome fusion was 6 mM Ca 2ϩ (Fig. 8) . To evaluate the effect of ceramide-1-phosphate on liposome fusion, complex liposomes were prepared by replacing 50% of the sphingomyelin with ceramide-1-phosphate (10% final phospholipid composition). The incorporation of ceramide-1-phosphate into complex liposomes had no effect on threshold fusion Ca 2ϩ requirements. However, the rate and extent of fusion were significantly increased.
Sphingomyelinase D was used to understand further the potential effect of ceramide-1-phosphate on granule-plasma membrane fusion. The treatment of liposomes with sphingomyelinase D had no effect on Ca 2ϩ -dependent fusion thresholds. However, increasing concentrations of sphingomyelinase D resulted in an increase in both the initial rate of fusion as well as the total fusion of complex liposomes (Fig. 9B) . To determine the extent of phospholipid metabolism that occurred during our fusion assay, ceramide-1-phosphate generation in parallel experiments was quantitated (Fig. 9A) . Increasing concentrations of sphingomyelinase D were incubated with complex liposomes for 30 min at 37°C. The lipids were extracted and separated by thin layer chromatography. As expected, sphingomyelinase D produced a concentration-dependent conversion of sphingomyelin to ceramide-1-phosphate. An augmentation in fusogenicity was observed when as little as 0.45% of the membrane phospholipid composition was ceramide-1-phosphate. In parallel experiments performed in the absence of unlabeled liposomes only a minimal signal could be detected. Thus fusion was dependent on the presence of Ca 2ϩ and could not be explained by lysis of the labeled vesicles. Sphingomyelinase D alone was not fusogenic because no fusion occurred without either preincubation (phospholipid metabolism) or Ca modulating the functional behavior of PMN during phagocytosis. The signal that a cell receives depends upon the balance of production of bioactive lipids; thus, it is important that the role of ceramide-1-phosphate in PMN be elucidated. Our previous data indicate that the sphingomyelin pathway is important to PMN activation (9) . Phagocytosis of EIgG by suspended PMN stimulates a parallel increase in both neutral sphingomyelinase activity and ceramide within the first min of activation.
Ceramide may be further metabolized to ceramide phosphate by ceramide kinase or sphingosine and sphingosine-1-phosphate or N, N-dimethylsphingosine by the sequential action of either ceramidase and sphingosine kinase or ceramidase and methyltransferase, respectively (36 -38) . Although ceramide levels increase during phagocytosis, it may be one of those second messengers that is regulating phagocytosis. In this study it is reported that another enzyme, ceramide kinase, can mediate ceramide catabolism.
The present study identifies the existence of ceramide kinase activity in human neutrophils. This calcium-dependent ceramide kinase is localized to the plasma membrane and secretory vesicles based on the colocalization with the plasma membrane marker HLA and with the secretory vesicle marker latent alkaline phosphatase. Previous studies have shown that Fc receptor-mediated phagocytosis induces an increase in activity in a plasma membrane-associated neutral sphingomyelinase in fMLP-activated human PMN. The increase in neutral sphingomyelinase activity resulted in increased ceramide levels. The presence of ceramide kinase activity in the plasma membrane is consistent with these previously identified signaling events.
Ceramide kinase activity has been previously reported in HL-60 cells (21, 39) . Consistent with these earlier reports, PMN ceramide kinase activity was observed to be calcium-dependent and optimally active at physiologic calcium concentrations and neutral pH. The ceramide kinase activity is distinguishable from diacylglycerol kinase based on both substrate specificity and cation requirements. Ceramide kinase activity is also inhibited in the presence of phosphatidylserine, an activator of diacylglycerol kinase. Ceramide kinase activity increased in the PMN plasma membrane when the cells were activated with fMLP and EIgG, whereas diacylglycerol kinase activity failed to rise. These data contrast with those reported for human leukemia HL-60 cells. The ceramide kinase activity in this cell line, although separable from diglyceride kinase activity, was Mg 2ϩ -stimulable (21). Relatively little is known about the physiological function of ceramide kinase. Gomez-Munoz et al. reported that DNA synthesis could be stimulated by using synthetic short chain ceramide-1-phosphate (19) . The presence of ceramide kinase activity in synaptic vesicles has led to the suggestions that ceramide-1-phosphate may attenuate membrane charge, regulate vesicle transport, or mediate membrane fusion.
Phospholipid composition is known to play a significant role in membrane fusogenicity. Because exogenous sphingomyelinase has been observed to induce vesicle formation from the plasma membrane of macrophages, it seemed reasonable to ascertain whether ceramide-1-phosphate could affect membrane fusion. Experiments with synthetic phosphatidylcholine vesicles demonstrated that calcium-induced vesicle fusion was correlated with phosphatidic acid content. Because the phosphorylation of ceramide would produce an acidic phospholipid similar in structure to phosphatidic acid, the role of ceramide-1-phosphate in phospholipid-dependent vesicle fusion was explored. Complex liposomes were prepared with a phospholipid composition similar to that of PMN plasma membrane with and without the incorporation of ceramide-1-phosphate. Ceramide-1-phosphate enhanced phospholipid-dependent vesicle fusion.
Although direct incorporation of phospholipids into vesicles is an accepted method for controlling phospholipid composition, this method assumes that all phospholipids are equally distributed throughout the membrane and therefore cannot account for local pooling of individual phospholipids. The potential role of phosphatidic acid (40) and arachidonic acid (41) formation on membrane fusion events has been previously examined using exogenous phospholipases. The augmentation of phospholipid vesicle fusion by ceramide-1-phosphate was verified by the conversion of sphingomyelin to ceramide-1-phosphate with sphingomyelinase D. This augmentation was observed when as little as 0.5% (1% of the outer membrane leaflet) was ceramide-1-phosphate, suggesting that ceramide-1-phosphate formation potentially may play a positive regulatory role in PMN granuleplasma membrane fusion.
The fusogenic effects of ceramide-1-phosphate were distinct from those previously reported for proteins such as annexins and free fatty acids. These latter factors lower the calcium requirements and not the rate of membrane fusion (42) . Thus ceramide-1-phosphate serves as a cofactor for membrane fusion, a hypothesis that is currently under investigation.
